- ADVERTISEMENT
-
Louis's Most Popular
- ADVERTISEMENT
Search Results
240 results for dgse
Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns
Psychedelics could be a game-changer in treating mental health issues, creating substantial opportunities for top psychedelic stocks.
The 3 Best Gene Editing Stocks to Buy in July 2024
Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks.
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
There are more marketplace opportunities than just AI which is why these stocks that are outperforming Nvidia have done so well.
Why Did Annovis Bio (ANVS) Stock Close Up 80% Today?
ANVS stock closed up more than 75% today after Annovis announced encouraging clinical trial results for its Parkinson’s drug, buntanetap.
3 Top-Rated Gene Editing Stocks Actually Making Money
Profitable gene editing stocks make increasingly compelling investments as therapies commercialize this year and beyond.
3 Psychedelic Stocks to Buy on the Dip: Summer 2024
These are three of the best psychedelic stocks to buy on the dip for potentially lucrative future growth and returns.
You’ve Been Warned! 3 Gene Editing Stocks to Buy Now or Regret Forever.
The best gene editing stocks to buy are those with strong tehnogical applications and genuine commercialization prospects.
3 Stocks This Amazon-Backed AI Says Will Turn $1K into $1M by 2030
These high-risk, high-reward stocks have the potential to turn $1K into $1M by 2030, according to Amazon-backed AI Claude 3.5 Sonnet.
ALT Stock Alert: Altimmune Pops on Weight-Loss Drug Findings
Altimmune (ALT) stock is soaring and trending after the company reported data on its GLP-1 weight-loss drug today.
The 3 Healthiest Healthcare Stocks to Buy for a Huge Dose of Profits
Explore three top growth-ready healthcare stocks to buy amid rising demand for healthcare services globally.
Falling Knives: 3 Stocks Getting the Cold Shoulder From Analysts
Uncover key insights on stocks with negative analyst sentiment, including major moves by Alphabet, Nike and ResMed.
Rags to Riches: 3 Gene Editing Stocks That Could Make Early Investors Rich
Gene editing is a game-changer, creating substantial opportunities for some of the leading gene editing stocks.
Why Is GeoVax (GOVX) Stock Up 110% Today?
With Covid-19 still representing a major problem, GeoVax’s next-gen Covid vaccine may help, bolstering GOVX stock.
The 3 Smartest Biotech Stocks to Buy With $5K Right Now
With global obesity numbers bursting at the seams, some of the smartest biotech stocks to buy are those with weight loss drugs.
The 7 Best Under $10 Stocks to Buy in July 2024
We’re finding big opportunities in some of the best stocks under $10 a share. In fact, here are seven you may want to jump into…
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
Invest in the top biotech stocks to buy, as the sector pivots from pandemic-driven vaccine sales to solutions for chronic conditions.
3 Renewable Energy Stocks to Turn Your Portfolio Into a Money Machine
As green energy adoption accelerates, wise investors might want to look into renewable energy stocks poised for growth.
Small Biotechs Are Valuable for Big Pharma… and Your Portfolio
Historically, pharmaceutical companies have worked their way through their down cycles by painstakingly developing new drugs, in the hopes that some of them become future…
3 Cannabis Stocks That Could Make Your Grandchildren Rich
These cannabis stocks offer long-term growth potential anchored by solid operational models and diversified revenue streams today.
Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
How much Sarepta can hope to earn from Elevidys is unclear due to its cost, $3 million, and that it’s not a cure. Yet SRPT…
Why Is Cara Therapeutics (CARA) Stock Down 27% Today?
Cara Therapeutics stock is down on Thursday as investors learn of a failed clinical trial and the company considering strategic alternatives.
1 – 10 of 240 results
